AUROBINDO PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 12.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 12.0%
Mon, 13 Aug

AUROBINDO PHARMA has announced its results for the quarter ended June 2018. Here is a detailed performance review of the same:

AUROBINDO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-17*
3
Mar-18*
3
Jun-18*
QoQ ChangeYoY Change
Net SalesRs m36,78840,49142,5035.0%15.5%
Other incomeRs m333438437-0.2%31.5%
TurnoverRs m37,12040,92942,9404.9%15.7%
ExpensesRs m28,56032,61035,3928.5%23.9%
Gross profitRs m8,2287,8847,111-9.8%-13.6%
DepreciationRs m1,3121,5661,545-1.3%17.8%
InterestRs m16924729519.5%75.1%
Profit before taxRs m7,0806,5095,707-12.3%-19.4%
TaxRs m1,9101,2241,155-5.6%-39.5%
Profit after taxRs m5,1705,2854,552-13.9%-12.0%
Gross profit margin%22.419.516.7
Effective tax rate%27.018.820.2
Net profit margin%13.912.910.6
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 15.5% on a year-on-year (YoY) basis. The expenses were up by 23.9% YoY during the same period.
  • The company's operating profit declined by 13.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 16.7% in 1QFY19 as against 22.4% in 1QFY18.
  • Depreciation charges and finance costs increased by 17.8% YoY and 75.1% YoY, respectively.
  • Other income increased by 31.5% YoY during the quarter.
  • Net profit for the quarter declined by 12.0% YoY. Net profit margins during the quarter declined from 13.9% in 1QFY18 to 10.6% in 1QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 5.0% on a quarter-on-quarter (QoQ) basis. The expenses were up by 8.5% QoQ during the same period.
  • The company's operating profit declined by 9.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 16.7% in 1QFY19 as against 19.5% in 4QFY18.
  • Net profit for the quarter declined by 13.9% QoQ, while net profit margins declined from 12.9% in 4QFY18 to 10.6% in 1QFY19.

To see how AUROBINDO PHARMA has performed over the last eight quarters, please visit here.

AUROBINDO PHARMA Share Price Performance

Over the last one year, AUROBINDO PHARMA share price has moved up from Rs 704.8 to Rs 617.0, registering a Loss of Rs 87.9 or around 12.5%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,318.8 (up 0.5%). Over the last one year it has moved up from 12,807.8 to 14,318.8, a gain of 1,511 points (up 11.8%).

Overall, the S&P BSE SENSEX is up 19.3% over the year.

Current Valuations

At the current price of Rs 617.0, the price to earnings (P/E) ratio of AUROBINDO PHARMA stands at 15.3 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.9 times.

Equitymaster requests your view! Post a comment on "AUROBINDO PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 12.0%". Click here!

  

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 38.6% YoY). Sales on the other hand came in at Rs 54 bn (up 28.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Buy the Best Safe Stocks in 2020(The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

The Best Asset Class to Invest in 2020(Fast Profits Daily)

Jan 24, 2020

Why I'm most bullish on this asset class above all else in 2020.

Small is Beautiful in 2020 (A Prediction You Don't Want to Miss)(Profit Hunter)

Jan 17, 2020

As always Apurva will predict the best asset class to invest in in the coming year, last year he predicted gold and he was bang on! And this year he predicts... wait, you have to read to find out! Don't miss this.

The Smallcap Rebound Has Begun (13 Stocks Up Over 20% in the last Month)(Profit Hunter)

Jan 21, 2020

The best smallcap stocks to bet on to get rich in this market rebound.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Jan 29, 2020 03:37 PM

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS